Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Li

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
Internal Medicine Journal|March 18, 2024
Pulmonary embolism response teams. A description of the first 36-month Australian experienceBapti Roy, Jin-Gun Cho, Luke Baker, et al.
British Journal of Anaesthesia|December 1, 2020
Controversies in airway management of COVID-19 patients: updated information and international expert consensus recommendationsHuafeng Wei, Bailin Jiang, Elizabeth C Behringer, et al.
Emerging Microbes & Infections|January 3, 2025
Novel digital droplet inverse PCR assay shows that natural clearance of hepatitis B infection is associated with fewer viral integrationsDong Li, Vikki Ho, Chiao-Fang Teng, et al.
The Australasian Journal of Dermatology|September 30, 2025
Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus StatementDaniella Kushnir-Grinbaum, Laita Bokhari, John Frewen, et al.
Molecular Oncology|June 6, 2015
PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patientsShannon N Westin, Zhenlin Ju, Russell R Broaddus, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2014
Discovery of substituted benzamides as follicle stimulating hormone receptor allosteric modulatorsHenry N Yu, Thomas E Richardson, Selva Nataraja, et al.
Nucleic Acids Research|December 12, 2025
Medicines, Diseases, Indications, and Contraindications (MeDIC): a foundational resource to support drug repurposingMarcello DeLuca, Nico Matentzoglu, Elliott Sharp, et al.
Journal of Alzheimer'S Disease : JAD|August 18, 2006
Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disordersFadi Abdi, Joseph F Quinn, Joseph Jankovic, et al.
The Australasian Journal of Dermatology|August 6, 2025
Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients-Results From an Australian Expert Consensus ExerciseMeryl Thomas, Madeline Hankins, Emadodin Darchini-Maragheh, et al.
Breast Cancer Research : BCR|July 12, 2014
Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancerPatrick C O'Leary, Marta Terrile, Malgorzata Bajor, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
Internal Medicine Journal|March 18, 2024
Pulmonary embolism response teams. A description of the first 36-month Australian experienceBapti Roy, Jin-Gun Cho, Luke Baker, et al.
British Journal of Anaesthesia|December 1, 2020
Controversies in airway management of COVID-19 patients: updated information and international expert consensus recommendationsHuafeng Wei, Bailin Jiang, Elizabeth C Behringer, et al.
Emerging Microbes & Infections|January 3, 2025
Novel digital droplet inverse PCR assay shows that natural clearance of hepatitis B infection is associated with fewer viral integrationsDong Li, Vikki Ho, Chiao-Fang Teng, et al.
The Australasian Journal of Dermatology|September 30, 2025
Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus StatementDaniella Kushnir-Grinbaum, Laita Bokhari, John Frewen, et al.
Molecular Oncology|June 6, 2015
PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patientsShannon N Westin, Zhenlin Ju, Russell R Broaddus, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2014
Discovery of substituted benzamides as follicle stimulating hormone receptor allosteric modulatorsHenry N Yu, Thomas E Richardson, Selva Nataraja, et al.
Nucleic Acids Research|December 12, 2025
Medicines, Diseases, Indications, and Contraindications (MeDIC): a foundational resource to support drug repurposingMarcello DeLuca, Nico Matentzoglu, Elliott Sharp, et al.
Journal of Alzheimer'S Disease : JAD|August 18, 2006
Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disordersFadi Abdi, Joseph F Quinn, Joseph Jankovic, et al.
The Australasian Journal of Dermatology|August 6, 2025
Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients-Results From an Australian Expert Consensus ExerciseMeryl Thomas, Madeline Hankins, Emadodin Darchini-Maragheh, et al.
Breast Cancer Research : BCR|July 12, 2014
Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancerPatrick C O'Leary, Marta Terrile, Malgorzata Bajor, et al.
Pageof 15